Allworth Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552K | Sell |
11,357
-203
| -2% | -$9.87K | ﹤0.01% | 803 |
|
|
2025
Q1 | $452K | Sell |
11,560
-3,518
| -23% | -$138K | ﹤0.01% | 705 |
|
|
2024
Q4 | $666K | Buy |
15,078
+14,398
| +2,117% | +$636K | ﹤0.01% | 617 |
|
|
2024
Q3 | $31.9K | Sell |
680
-1,722
| -72% | -$80.9K | ﹤0.01% | 1610 |
|
|
2024
Q2 | $131K | Buy |
2,402
+1,684
| +235% | +$91.9K | ﹤0.01% | 965 |
|
|
2024
Q1 | $48.9K | Sell |
718
-32
| -4% | -$2.18K | ﹤0.01% | 1314 |
|
|
2023
Q4 | $47K | Buy |
750
+27
| +4% | +$1.69K | ﹤0.01% | 1226 |
|
|
2023
Q3 | $32.8K | Sell |
723
-1
| -0.1% | -$45 | ﹤0.01% | 1274 |
|
|
2023
Q2 | $40.6K | Buy |
724
+2
| +0.3% | +$112 | ﹤0.01% | 1190 |
|
|
2023
Q1 | $32.7K | Sell |
722
-18
| -2% | -$814 | ﹤0.01% | 1236 |
|
|
2022
Q4 | $30.1K | Sell |
740
-3
| -0.4% | -$122 | ﹤0.01% | 1201 |
|
|
2022
Q3 | $49K | Buy |
743
+6
| +0.8% | +$396 | ﹤0.01% | 963 |
|
|
2022
Q2 | $45K | Buy |
737
+128
| +21% | +$7.82K | ﹤0.01% | 943 |
|
|
2022
Q1 | $38K | Buy |
609
+497
| +444% | +$31K | ﹤0.01% | 989 |
|
|
2021
Q4 | $8K | Hold |
112
| – | – | ﹤0.01% | 1459 |
|
|
2021
Q3 | $13K | Buy |
112
+32
| +40% | +$3.71K | ﹤0.01% | 1171 |
|
|
2021
Q2 | $13K | Hold |
80
| – | – | ﹤0.01% | 962 |
|
|
2021
Q1 | $10K | Hold |
80
| – | – | ﹤0.01% | 978 |
|
|
2020
Q4 | $12K | Buy |
+80
| New | +$12K | ﹤0.01% | 785 |
|